Aromatic amino acid decarboxylase deficiency: Molecular and metabolic basis and therapeutic outlook

Aromatic-l-amino acid decarboxylase (AADC) deficiency is an ultra-rare inherited autosomal recessive disorder characterized by sharply reduced synthesis of dopamine as well as other neurotransmitters. Symptoms, including hypotonia and movement disorders (especially oculogyric crisis and dystonia) as...

Full description

Saved in:
Bibliographic Details
Main Authors: Himmelreich, Nastassja (Author) , Montioli, Riccardo (Author) , Bertoldi, Mariarita (Author) , Carducci, Carla (Author) , Leuzzi, Vincenzo (Author) , Gemperle, Corinne (Author) , Berner, Todd (Author) , Hyland, Keith (Author) , Thöny, Beat (Author) , Hoffmann, Georg F. (Author) , Voltattorni, Carla B. (Author) , Blau, Nenad (Author)
Format: Article (Journal)
Language:English
Published: 27 March 2019
In: Molecular genetics and metabolism
Year: 2019, Volume: 127, Issue: 1, Pages: 12-22
ISSN:1096-7206
DOI:10.1016/j.ymgme.2019.03.009
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.ymgme.2019.03.009
Verlag, lizenzpflichtig: http://www.sciencedirect.com/science/article/pii/S1096719218307868
Get full text
Author Notes:Nastassja Himmelreich, Riccardo Montioli, Mariarita Bertoldi, Carla Carducci, Vincenzo Leuzzi, Corinne Gemperle, Todd Berner, Keith Hyland, Beat Thöny, Georg F. Hoffmann, Carla B. Voltattorni, Nenad Blau

MARC

LEADER 00000caa a2200000 c 4500
001 1691538493
003 DE-627
005 20230428055206.0
007 cr uuu---uuuuu
008 200304s2019 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.ymgme.2019.03.009  |2 doi 
035 |a (DE-627)1691538493 
035 |a (DE-599)KXP1691538493 
035 |a (OCoLC)1341309303 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Himmelreich, Nastassja  |e VerfasserIn  |0 (DE-588)1067678972  |0 (DE-627)819077003  |0 (DE-576)426841123  |4 aut 
245 1 0 |a Aromatic amino acid decarboxylase deficiency  |b Molecular and metabolic basis and therapeutic outlook  |c Nastassja Himmelreich, Riccardo Montioli, Mariarita Bertoldi, Carla Carducci, Vincenzo Leuzzi, Corinne Gemperle, Todd Berner, Keith Hyland, Beat Thöny, Georg F. Hoffmann, Carla B. Voltattorni, Nenad Blau 
264 1 |c 27 March 2019 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Available online 27 March 2019 
500 |a Gesehen am 04.03.2020 
520 |a Aromatic-l-amino acid decarboxylase (AADC) deficiency is an ultra-rare inherited autosomal recessive disorder characterized by sharply reduced synthesis of dopamine as well as other neurotransmitters. Symptoms, including hypotonia and movement disorders (especially oculogyric crisis and dystonia) as well as autonomic dysfunction and behavioral disorders, vary extensively and typically emerge in the first months of life. However, diagnosis is difficult, requiring analysis of metabolites in cerebrospinal fluid, assessment of plasma AADC activity, and/or DNA sequence analysis, and is frequently delayed for years. New metabolomics techniques promise early diagnosis of AADC deficiency by detection of 3-O-methyl-dopa in serum or dried blood spots. A total of 82 dopa decarboxylase (DDC) variants in the DDC gene leading to AADC deficiency have been identified and catalogued for all known patients (n=123). Biochemical and bioinformatics studies provided insight into the impact of many variants. c.714+4A>T, p.S250F, p.R347Q, and p.G102S are the most frequent variants (cumulative allele frequency=57%), and c.[714+4A>T];[714+4A>T], p.[S250F];[S250F], and p.[G102S];[G102S] are the most frequent genotypes (cumulative genotype frequency=40%). Known or predicted molecular effect was defined for 79 variants. Most patients experience an unrelenting disease course with poor or no response to conventional medical treatments, including dopamine agonists, monoamine oxidase inhibitors, and pyridoxine derivatives. The advent of gene therapy represents a potentially promising new avenue for treatment of patients with AADC deficiency. Clinical studies based on the direct infusion of engineered adeno-associated virus type 2 vectors into the putamen have demonstrated acceptable safety and tolerability and encouraging improvement in motor milestones and cognitive symptoms. The success of gene therapy in AADC deficiency treatment will depend on timely diagnosis to facilitate treatment administration before the onset of neurologic damage. 
650 4 |a Dopamine 
650 4 |a Genetic diseases, inborn 
650 4 |a Genetic therapy 
650 4 |a Neurotransmitters 
650 4 |a Pyridoxal phosphate 
650 4 |a Rare diseases 
700 1 |a Montioli, Riccardo  |e VerfasserIn  |4 aut 
700 1 |a Bertoldi, Mariarita  |e VerfasserIn  |4 aut 
700 1 |a Carducci, Carla  |e VerfasserIn  |4 aut 
700 1 |a Leuzzi, Vincenzo  |e VerfasserIn  |4 aut 
700 1 |a Gemperle, Corinne  |e VerfasserIn  |4 aut 
700 1 |a Berner, Todd  |e VerfasserIn  |4 aut 
700 1 |a Hyland, Keith  |e VerfasserIn  |4 aut 
700 1 |a Thöny, Beat  |e VerfasserIn  |4 aut 
700 1 |a Hoffmann, Georg F.  |d 1957-  |e VerfasserIn  |0 (DE-588)115652868  |0 (DE-627)077386116  |0 (DE-576)261230042  |4 aut 
700 1 |a Voltattorni, Carla B.  |e VerfasserIn  |4 aut 
700 1 |a Blau, Nenad  |d 1946-  |e VerfasserIn  |0 (DE-588)11474632X  |0 (DE-627)500421803  |0 (DE-576)176516107  |4 aut 
773 0 8 |i Enthalten in  |t Molecular genetics and metabolism  |d Orlando, Fla. : Academic Press, 1998  |g 127(2019), 1, Seite 12-22  |h Online-Ressource  |w (DE-627)268125260  |w (DE-600)1471393-7  |w (DE-576)106869493  |x 1096-7206  |7 nnas  |a Aromatic amino acid decarboxylase deficiency Molecular and metabolic basis and therapeutic outlook 
773 1 8 |g volume:127  |g year:2019  |g number:1  |g pages:12-22  |a Aromatic amino acid decarboxylase deficiency Molecular and metabolic basis and therapeutic outlook 
856 4 0 |u https://doi.org/10.1016/j.ymgme.2019.03.009  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u http://www.sciencedirect.com/science/article/pii/S1096719218307868  |x Verlag  |z lizenzpflichtig 
951 |a AR 
992 |a 20200304 
993 |a Article 
994 |a 2019 
998 |g 11474632X  |a Blau, Nenad  |m 11474632X:Blau, Nenad  |d 910000  |d 910500  |e 910000PB11474632X  |e 910500PB11474632X  |k 0/910000/  |k 1/910000/910500/  |p 12  |y j 
998 |g 115652868  |a Hoffmann, Georg F.  |m 115652868:Hoffmann, Georg F.  |d 910000  |d 910500  |e 910000PH115652868  |e 910500PH115652868  |k 0/910000/  |k 1/910000/910500/  |p 10 
998 |g 1067678972  |a Himmelreich, Nastassja  |m 1067678972:Himmelreich, Nastassja  |d 910000  |d 910500  |e 910000PH1067678972  |e 910500PH1067678972  |k 0/910000/  |k 1/910000/910500/  |p 1  |x j 
999 |a KXP-PPN1691538493  |e 3603683110 
BIB |a Y 
SER |a journal 
JSO |a {"note":["Available online 27 March 2019","Gesehen am 04.03.2020"],"recId":"1691538493","name":{"displayForm":["Nastassja Himmelreich, Riccardo Montioli, Mariarita Bertoldi, Carla Carducci, Vincenzo Leuzzi, Corinne Gemperle, Todd Berner, Keith Hyland, Beat Thöny, Georg F. Hoffmann, Carla B. Voltattorni, Nenad Blau"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"relHost":[{"title":[{"title":"Molecular genetics and metabolism","title_sort":"Molecular genetics and metabolism"}],"part":{"issue":"1","text":"127(2019), 1, Seite 12-22","volume":"127","pages":"12-22","year":"2019"},"origin":[{"dateIssuedDisp":"1998-","publisherPlace":"Orlando, Fla.","publisher":"Academic Press","dateIssuedKey":"1998"}],"physDesc":[{"extent":"Online-Ressource"}],"pubHistory":["63.1998 -"],"type":{"bibl":"periodical","media":"Online-Ressource"},"id":{"eki":["268125260"],"issn":["1096-7206"],"zdb":["1471393-7"]},"disp":"Aromatic amino acid decarboxylase deficiency Molecular and metabolic basis and therapeutic outlookMolecular genetics and metabolism","language":["eng"],"recId":"268125260","note":["Gesehen am 14.02.20"]}],"person":[{"roleDisplay":"VerfasserIn","family":"Himmelreich","given":"Nastassja","role":"aut","display":"Himmelreich, Nastassja"},{"display":"Montioli, Riccardo","role":"aut","roleDisplay":"VerfasserIn","family":"Montioli","given":"Riccardo"},{"given":"Mariarita","roleDisplay":"VerfasserIn","family":"Bertoldi","display":"Bertoldi, Mariarita","role":"aut"},{"given":"Carla","roleDisplay":"VerfasserIn","family":"Carducci","display":"Carducci, Carla","role":"aut"},{"given":"Vincenzo","family":"Leuzzi","roleDisplay":"VerfasserIn","role":"aut","display":"Leuzzi, Vincenzo"},{"role":"aut","display":"Gemperle, Corinne","family":"Gemperle","roleDisplay":"VerfasserIn","given":"Corinne"},{"role":"aut","display":"Berner, Todd","family":"Berner","roleDisplay":"VerfasserIn","given":"Todd"},{"given":"Keith","roleDisplay":"VerfasserIn","family":"Hyland","display":"Hyland, Keith","role":"aut"},{"role":"aut","display":"Thöny, Beat","given":"Beat","family":"Thöny","roleDisplay":"VerfasserIn"},{"role":"aut","display":"Hoffmann, Georg F.","given":"Georg F.","roleDisplay":"VerfasserIn","family":"Hoffmann"},{"given":"Carla B.","roleDisplay":"VerfasserIn","family":"Voltattorni","display":"Voltattorni, Carla B.","role":"aut"},{"family":"Blau","roleDisplay":"VerfasserIn","given":"Nenad","display":"Blau, Nenad","role":"aut"}],"origin":[{"dateIssuedKey":"2019","dateIssuedDisp":"27 March 2019"}],"language":["eng"],"title":[{"title_sort":"Aromatic amino acid decarboxylase deficiency","title":"Aromatic amino acid decarboxylase deficiency","subtitle":"Molecular and metabolic basis and therapeutic outlook"}],"id":{"doi":["10.1016/j.ymgme.2019.03.009"],"eki":["1691538493"]}} 
SRT |a HIMMELREICAROMATICAM2720